WebNews

Please enter a web search for web results.

NewsWeb

MPR
empr. com > news > linzess-fda-approval-pediatric-functional-constipation-ages-2-plus

FDA Expands Linzess Indication for Pediatric Functional Constipation

3+ hour, 50+ min ago  (333+ words) The Food and Drug Administration (FDA) has expanded the approval of Linzess" (linaclotide) for functional constipation to include children as young as 2 years old, lowering the previously approved age threshold of 6 years and older. The approval in younger patients is…...

Symbols: sbs-if
Eurek Alert!
eurekalert. org > news-releases > 1124421

Why endometriosis causes such chronic debilitating pain

1+ mon, 1+ week ago  (536+ words) PULLMAN, Wash. " Repeated menstrual cycles may do more than trigger endometriosis. They may rewire the brain. That is the key finding from a new Washington State University study showing that recurring inflammation linked to the disease can sensitize the nervous…...

Yahoo Finance
finance. yahoo. com > sectors > healthcare > articles > fda-approves-linzess-linaclotide-pediatric-140000816. html

FDA Approves Use of LINZESS" (linaclotide) in Pediatric Patients Two Years of Age and Older with Functional Constipation (FC)

4+ hour, 16+ min ago  (459+ words) " Expanded indication extends availability to children ages 2-5 with FC; previously approved in pediatric patients 6 years of age and older " LINZESS remains the first-and-only FDA-approved prescription therapy for pediatric FC " Functional constipation in children is a chronic condition characterized by hard,…...

Symbols: sbs-if,nasdaq:jagx
Healio
healio. com > news > gastroenterology > 20/26/0526 > early-consistent-support-critical-to-prevent-relapse-after-alcoholassociated-hepatitis

Drinking days, education predict alcohol relapse after hepatitis

5+ hour, 9+ min ago  (61+ words) Nearly a quarter of patients who beat the high short-term mortality odds of alcohol-associated hepatitis returned to drinking within 90 days of recovery, according to study results published in Alcohol Clinical & Experimental Research. “ We were surprised by how common…...

Symbols: acc.26
Clinical Lab Products
clpmag. com > disease-states > cancer > roche-launches-liver-disease-algorithm-suite

Roche Launches Algorithm Suite for Chronic Liver Disease Management

6+ hour, 43+ min ago  (297+ words) May 27, 2026 | Analytical Software Systems, Cancer, Diagnostic Technologies | Roche launched its Liver Disease Panel, a suite of certified algorithms designed to support clinicians in the identification and management of chronic liver disease (CLD). The panel combines biomarker-based diagnostics with digital algorithms to…...

Symbols: mhc-ii,nasdaq:sgmt,nasdaq:asmb,nasdaq:mirm,btc-usd,lthm.cn
Bluefield Daily Telegraph
bdtonline. com > news > nation_world > microbiome-symposium > image_a373d535-c149-54e6-a430-99c7282b7a5b. html

Microbiome Symposium | Nation/World | bdtonline. com

8+ hour, 24+ min ago  (133+ words) Microbiome Symposium Bluefield Daily Telegraph Severe Thunderstorm Watch from WED 1: 13 PM EDT until WED 9: 00 PM EDT IMAGE DISTRIBUTED FOR CITY OF HOPE - Leading microbiome researchers from the nation's top cancer centers present the latest science on how gut health shapes…...

Symbols: btc-usd
Harvard SEAS
seas. harvard. edu > news > leah-lourencos-senior-project-manufacturing-immune-cells-inflammatory-bowel-disease

Leah Lourenco's senior project: Manufacturing immune cells for inflammatory bowel disease

11+ hour, 4+ min ago  (222+ words) For her senior capstone project, Leah Lourenco developed a system for manufacturing immune cells for inflammatory bowel disease (Eliza Grinnell/SEAS) Engineering Design Projects (ES 100), the capstone course at the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS),…...

Symbols: nasdaq:mcrb,nyse:mrk
Journal-News. com
journal-news. com-news. com

Microbiome Symposium | Nation & World

18+ hour, 5+ min ago  (118+ words) Microbiome Symposium Journal-News. com IMAGE DISTRIBUTED FOR CITY OF HOPE - "The Next Frontier of Cancer Prevention and Care: The Microbiome," symposium opening included opening remarks from Secretary Kennedy, followed by a fireside conversation with Bhattacharya, George Sigounas, Ph. D. , Chief Scientific…...

Symbols: btc-usd
Rutland Herald
rutlandherald. com > news > business > precision-biosciences-announces-new-and-late-breaking-pbgene-hbv-clinical-data-from-the-eliminate-b > article_c4b8c072-1773-523b-a2ed-2997ec5fecd2. html

Precision Bio Sciences Announces New and Late-Breaking PBGENE-HBV Clinical Data from the ELIMINATE-B Study at European Association for the Study of the Liver Congress 2026

15+ hour, 46+ min ago  (194+ words) Rutland Herald Precision Bio Sciences Announces New and Late-Breaking PBGENE-HBV Clinical Data from the ELIMINATE-B Study at European Association for the Study of the Liver Congress 2026 DURHAM, N. C. --(BUSINESS WIRE)--May 27, 2026-- Precision Bio Sciences, Inc. (Nasdaq: DTIL), a clinical stage gene…...

Symbols: nyse:gsk
Gene Online News
geneonline. com > roche-introduces-first-certified-liver-disease-panel-algorithms-for-enhanced-patient-management

Roche Introduces First Certified Liver Disease Panel Algorithms for Enhanced Patient Management

16+ hour, 36+ min ago  (119+ words) geneonline. com Roche Introduces First Certified Liver Disease Panel Algorithms for Enhanced Patient Management Roche introduced the Liver Disease Panel, a set of certified algorithms designed to aid in the management of chronic liver disease. The panel represents a new…...

Symbols: nasdaq:gild